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ABSTRACT 
 
Objective: The overall goal for this study was to conduct a segment analysis of the pharmacist workforce during 2009 based upon 
time spent in medication providing and in patient care services.  
Methods: Data for this study were obtained from the 2009 National Pharmacist Workforce Survey in which a random sample of 3,000 
pharmacists was selected. Cluster analysis was used for identifying pharmacist segments and descriptive statistics were used for 
describing and comparing segments.  
Results: Of the 2,667 surveys that were presumed to be delivered to a pharmacist, 1,395 were returned yielding a 52.3% overall 
response rate. Of these, 1,200 responses were usable for cluster analysis. Findings from this study revealed five segments of 
pharmacists: (1) Medication Providers, (2) Medication Providers who also Provide Patient Care, (3) Other Activity Pharmacists, (4) 
Patient Care Providers Who also Provide Medication, and (5) Patient Care Providers. The results showed that, in 2009, 41% of U.S. 
pharmacists were devoted wholly to medication providing (Medication Providers). Forty-three percent of pharmacists contributed 
significantly to patient care service provision (Medication Providers who also Provide Patient Care, Patient Care Providers who also 
Provide Medication, and Patient Care Providers) and the remaining 16% (Other Activity Pharmacists) contributed most of their time 
to business / organization management, research, education, and other health-system improvement activities.  
Conclusions: Based on the findings, we propose that the pharmacy profession currently has, and will continue to build, capacity for 
contributing to the U.S. health care system in new roles for which they have been identified. However, as shifts in professional roles 
occur, a great deal of capacity is required related to new service provision. Resources are scarce, so an understanding of the most 
appropriate timing for making such changes can lead to cost-effective use of limited resources for improving patient care.   
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Introduction 
 
Health care cannot function without medicines and 
pharmacists serve important roles for helping assure that the 
use of medicines results in the highest likelihood of achieving 
desired health and economic outcomes. In addition to the 
safe and efficient distribution and provision of medications, 
pharmacists have provided clinical expertise regarding 
selection, handling, preparation, procurement, and utilization 
of medications in patients [1] and, more recently, making 
sure that drugs reach their full potential for patients in 
society [2]. This implies a use of medications that is safe, 
effective, appropriate, affordable, cost-effective, efficient, 
and specific to the needs of a given patient [3-6].  
Pharmacists have been identified as important contributors 
to the healthcare system serving such expanded roles as (1) 
medication care coordinators for patient-centered medical 
homes [7-8] and primary care teams [9-12], (2) members of 
chronic disease management teams that focus on ‘episodes’ 
of care in which related services are packaged together [11, 
13-14], and (3) being the healthcare professional responsible 
for ensuring optimal medication therapy outcomes through 
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medication therapy management (MTM) service provision [3, 
11, 15-22]. 
 
Continued growth in medication use by society and the 
expansion of the pharmacist’s role in direct patient care 
continue to generate demand for pharmacist expertise and 
services [23]. At the same time, increased efficiencies for 
pharmacists’ medication providing roles have been achieved 
through the use of advanced logistics (e.g. centralized fill), 
technicians, and technology (e.g. bar code scanning, e-
prescribing, robotics) [23]. It appears that the pharmacy 
profession has reached a point in which new roles for 
pharmacists are being adopted [1-22] and traditional roles 
are being filled by other workers, systems, or technology [23].   
 
As such points are reached, a great deal of capacity is 
required related to new service provision as well as strategic 
decisions regarding educational training,  professional 
training and redeployment, updates to practice acts and 
regulations, new documentation and billing systems, 
enhanced information exchange, infrastructure, technology, 
policy, and new business models [24, 25]. Resources are 
scarce, so an understanding of the most appropriate timing 
for making such changes can lead to cost-effective use of 
limited resources for improving patient care [25].   
 
To help ensure the profession’s capacity for its emerging roles 
in health care, the pharmacy profession has become more 
patient focused resulting in reforms for both pharmacy 
education and practice [26]. On June 30, 2004, the 
Accreditation Council for Pharmacy Education standards for 
five-year Bachelors of Pharmacy programs expired and the 
six-year Doctor of Pharmacy (Pharm.D.) became the sole 
accredited professional degree for pharmacy in the United 
States (www.acpe-accredit.org). In addition to the Pharm.D. 
as the entry-level professional degree for pharmacists, 
specialized residency training for pharmacists has increased 
(www.ashp.org). It is estimated that 2,300 (23 percent) of the 
roughly 10,000 pharmacy school graduates in 2008 sought 
residency training after graduation (www.ashp.org).  
 
As a result of the evolution in pharmacy education, 
pharmacists are now trained with a focus and level of 
expertise in medication therapy management that exceeds 
any other health care provider’s *15+. Individuals graduating 
with a Pharm.D. degree have the knowledge, skills and 
expertise to optimize therapeutic outcomes and improve the 
medication use system. As a result, pharmacists have gained 
recognition as “medication therapy experts” *15+.  
 
Due to changes in how pharmacists have been trained over 
time, not all pharmacists currently posses the same set of 
competencies and experiences. In addition, pharmacists 
differ in terms of their work activities [27]. In light of the 
recognition of pharmacists’ expanded roles and the need for 
strategic decisions regarding the cost-effective use of limited 
resources, our goal for this study was to conduct a segment 
analysis of the pharmacist workforce during 2009. Such a 
segmentation approach would identify key clusters 
(segments) of the pharmacist workforce and provide a 
description of their characteristics so that projections could 
be made regarding future pharmacy profession capacity as 
cohorts of pharmacists exit the workforce and newly trained 
pharmacists join the workforce. In light of the expansion of 
the pharmacist’s role in direct patient care and congruent 
training in such roles, our segment analysis was based upon 
pharmacists’ time devoted to medication provision (their 
traditional role) and to patient care services (their emergent 
role). 
 
Study Objectives 
 
The overall goal for this study was to conduct a segment 
analysis of the pharmacist workforce during 2009. The 
objectives were to: 
1. Identify segments of pharmacists based upon time 
spent in medication providing and patient care 
services. 
2. Describe segments according to demographic 
characteristics. 
3. Describe segments according to work contributions. 
4. Describe segments by work setting. 
5. Describe segments according to work activities. 
6. Describe age cohorts and year of licensure cohorts 
to identify trends that may impact future pharmacist 
capacity for contributing to the U.S. health care 
system. 
 
Methods 
 
Data for this study were obtained from the 2009 National 
Pharmacist Workforce Survey in which a random sample of 
3,000 pharmacists was selected for a national, cross-
sectional, descriptive survey. [27]. Questions comprising each 
section of the survey were taken from previous workforce 
surveys conducted by members of the project team [28-29].  
 
We obtained a random sample of 3,000 licensed pharmacists 
in the United States from KM Lists, Inc., a company that 
maintains a list of licensed pharmacists in the United States 
from every state.  At the time of our study, this list contained 
249,381 unduplicated licensed individuals and was cleaned 
and updated whenever a state board of pharmacy provided 
an updated file. They have no states that refuse to give them 
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the information. A randomly selected sample of 3,000 names 
and mailing addresses from this file was selected and 
provided to us in electronic format. We incorporated this file 
into a database program to generate mailing labels for the 
survey.  
 
A mailed questionnaire with multiple follow-up was designed 
using principles from Dillman [30] in which a four-contact 
approach was utilized: (1) pre-notification letter, (2) survey 
packet, (3) postcard reminder, and (4) survey packet remailed 
to non-responders. Surveys were returned to the University 
of Minnesota, College of Pharmacy and processed for data 
entry. A database structure was created and responses coded 
according to the survey code book. Data were extracted from 
the database and analyzed for this report using a two-step 
cluster analysis, with SPSS version 16.0 statistical software. 
The SPSS two-step cluster analysis uses a scalable cluster 
algorithm. The first step of the analysis is to ‘pre-cluster’ each 
case (record) into many small sub-clusters through a 
sequential clustering approach. The second step of the 
analysis is to ‘cluster the sub-clusters’ resulting from step one 
into the final cluster solution using an agglomerative 
hierarchical clustering method. The log-likelihood distance 
measure (a probability-based distance) is applied for each 
step of the analysis so that both continuous and categorical 
variables can be used if so desired. 
 
For our analysis we utilized two continuous variables for 
defining clusters: (1) percent time spent in medication 
providing activities and (2) percent time spent in patient care 
activities at each respondent’s primary place of employment. 
These were two of the six work activities we included for the 
2009 survey which were defined as: 
 
 Medication Providing: preparing, distributing, and 
administering medication products, including associated 
consultation, interacting with patients about selection 
and use of over-the-counter products, and interactions 
with other professionals during the medication providing 
process. 
 
 Patient Care Services: assessing and evaluating patient 
medication-related needs, monitoring and adjusting 
patients’ treatments to attain desired outcome, and 
other services designed for patient care management. 
 
 Business / Organization Management: managing 
personnel, finances, and systems. 
 
 Research: discovery, development, and evaluation of 
products, services, and/or ideas. 
 
 Education: teaching, precepting, and mentoring of 
students/trainees. 
 
 Other Activities: any activities not described in other 
categories. 
 
Our primary goal was to identify pharmacist segments and 
describe them using descriptive statistics within the context 
of the new roles for pharmacists that we mentioned in the 
introduction of this paper. It should be noted that medication 
providing is an important patient care service and our use of 
the terminology “patient care services” may be confusing. For 
clarification, it should be noted that “medication providing” 
primarily uses the medication as the unit of focus for service 
provision. It is typically focused on prescription order 
fulfillment but includes an array of professional activities in 
which pharmacists are responsible to the technical functions 
of providing a prescription product, assuring that the correct 
drug product is provided, identifying and resolving drug-drug 
interactions, conversing with prescribers about dose or 
directions, and patient counseling about proper use.   
 
For the purpose of this study, the designation “patient care 
services” uses the patient as the unit of focus and can be 
provided independent from any medication being provided to 
the patient. This service typically is a team-based clinical role 
providing patient-centered medication therapy management, 
health improvement, and disease prevention services [31].  
 
After pharmacist segments were identified, we described 
them using Chi-Square and Analysis of Variance (ANOVA) 
statistics.  
 
Results 
 
Of the 3,000 individuals contained in our random sample, 333 
(11%) were considered “undeliverable or not applicable” for 
the study. Of the 2,667 surveys that were presumed to be 
delivered to a pharmacist, 1,395 were returned yielding a 
52.3% overall response rate. Responses received on August 
15, 2009 or later were not included for analysis. Thus, 1,391 
surveys were entered into our data file (52.2% usable 
response rate).  
 
For inclusion in cluster analysis, respondents needed to 
report both their percent time devoted to medication 
providing and to patient care services. Respondents who 
reported that they were: (1) retired, do not practice 
pharmacy at all, (2) employed in a career not related to 
pharmacy, or (3) unemployed were not asked the work 
activity questions and, thus, not included for analysis. 
Respondents who were included for analysis were those who 
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reported that they were: (1) practicing as a pharmacist, (2) 
employed in a pharmacy-related field or position, or (3) 
retired, but still working in pharmacy or employed part-time 
as a pharmacist. A total of 1,200 respondents provided usable 
responses for cluster analysis.  
 
Cluster analysis identified five segments of pharmacists that 
we labeled as: (1) Medication Provider, (2) Medication 
Provider who also provides Patient Care, (3) Other Activity 
Pharmacist, (4) Patient Care Provider who also Provides 
Medication, and (5) Patient Care Provider. Figure 1 shows the 
proportion of pharmacists in each of the five segments and 
Table 1 provides a description of each segment in terms of 
time devoted to medication providing and patient care 
services.  
 
Table 2 provides summary comparisons among the five 
segments in terms of (1) demographic characteristics, (2) 
work contributions, (3) work settings by column %, (4) work 
settings by row %, (5) time currently spent in work activities, 
and (6) time desired to spend in work activities. Chi-square 
and Analysis of Variance statistics were used for describing 
the segments. In light of the exploratory nature of our cluster 
analysis to identify segments, we treated ANOVA findings as 
exploratory as well. Complete results (including post hoc 
analysis ANOVA testing) are available from the corresponding 
author. The five pharmacist segments are discussed next. 
 
MEDICATION PROVIDERS 
In our study, this group (41% of pharmacists employed in 
pharmacy or in a pharmacy-related field) devoted an average 
of 88% of their time to medication providing and only 5% to 
patient care services as defined in this study. Table 2 shows 
that they were the oldest of the five segments, on average. 
Fifty-nine percent of this segment were male, only 17% had a 
PharmD degree, and only 3% had residency training. This 
segment contributed the fewest hours worked per week of 
any segment and 79% were working in urban areas with a 
population over 50,000. This segment of pharmacists 
primarily worked in community pharmacy practice settings 
(78%) and 60% of respondents who worked in community 
practice settings were identified as being in the “Medication 
Provider” segment of pharmacists. The findings showed that 
the Medication Providers would like to decrease the 
proportion of time they devote to medication providing (from 
88% to 71%) and increase the proportion of time they devote 
to patient care services (from 5% to 16%).  
 
MEDICATION PROVIDERS WHO ALSO PROVIDE PATIENT CARE 
This segment (25% of pharmacists employed in pharmacy or 
in a pharmacy-related field) devoted an average of 65% of 
their time to medication providing and 19% to patient care 
services as defined in this study. Table 2 shows that they 
were the second oldest of the five segments, on average. 
Fifty-two percent of this segment were male, only 17% had a 
PharmD degree, and only 4% had residency training. This 
segment contributed an average of 38 hours worked per 
week and 79% were working in urban areas with a population 
over 50,000. Two-thirds of this segment of pharmacists 
worked in community pharmacy practice settings (67%) and 
one-quarter (25%) worked in hospital practice settings. The 
results showed that the Medication Providers who also 
Provide Patient Care would like to decrease the proportion of 
time they devote to medication providing (from 65% to 52%) 
and increase the proportion of time they devote to patient 
care services (from 19% to 31%).  
 
OTHER ACTIVITY PHARMACISTS 
This segment (16% of pharmacists employed in pharmacy or 
in a pharmacy-related field) devoted an average of only 5% of 
their time to medication providing and only 3% to patient 
care services as defined in this study. Table 2 shows that they 
were the third oldest of the five segments, on average. Sixty 
percent of this segment were male, 42% had a PharmD 
degree, and 19% had residency training. This segment 
contributed the most hours worked per week of any segment 
and 93% were working in urban areas with a population over 
50,000. The findings showed that 45% of this segment of 
pharmacists worked in ‘other, setting not licensed as a 
pharmacy,’ and 30% worked in a hospital setting.  In addition, 
83% of respondents who worked in ‘other, setting not 
licensed as a pharmacy’ were identified as being in the “Other 
Activity Pharmacist” segment of pharmacists. Other Activity 
Pharmacists are currently spending about their desired time 
in the various work activities we studied.  
 
PATIENT CARE PROVIDERS WHO ALSO PROVIDE MEDICATION 
This segment (12% of pharmacists employed in pharmacy or 
in a pharmacy-related field) devoted an average of 33% of 
their time to medication providing and 43% to patient care 
services as defined in this study. Table 2 shows that they 
were the youngest of the five segments, on average. Sixty-
four percent of this segment were female, 40% had a PharmD 
degree, and 25% had residency training. This segment 
contributed the second fewest hours worked per week of any 
segment and 88% were working in urban areas with a 
population over 50,000. The results showed that 54% of this 
segment of pharmacists worked in hospital settings, 23% 
worked in community pharmacy practice settings, and 16% 
worked in ‘other, licensed pharmacy settings.’ The Patient 
Care Providers Who Also Provide Medication would like to 
decrease only slightly the proportion of time they devote to 
medication providing (from 33% to 26%), keep the time they 
devote to patient care about the same (43% actual and 44% 
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desired), but increase slightly the proportion of time they 
devote to research and education.   
 
PATIENT CARE PROVIDERS 
In our study, this group (6% of pharmacists employed in 
pharmacy or in a pharmacy-related field) devoted an average 
of just 5% of their time to medication providing and 82% to 
patient care services as defined in this study. Table 2 shows 
that they were the second youngest of the five segments, on 
average. Fifty-nine percent of this segment were female, 53% 
had a PharmD degree, and 26% had residency training. This 
segment contributed the second highest number of hours 
worked per week of any segment and 92% were working in 
urban areas with a population over 50,000. Almost two-thirds 
(64%) of this segment worked in hospital pharmacy practice 
settings and less than 1% of respondents who worked in 
community practice settings were identified as being in the 
“Patient Care Provider” segment of pharmacists. Patient Care 
Provider Pharmacists are currently spending about their 
desired time in the various work activities we studied.  
 
AGE AND YEAR OF LICENSURE COHORTS 
Tables 3 and 4 summarize comparisons for U.S. pharmacist 
age and year of licensure cohorts and provide insight 
regarding future pharmacy profession capacity as cohorts of 
pharmacists exit the workforce and newly trained 
pharmacists join the workforce. For example, Table 3 shows 
that pharmacists over the age of 60 are typically male, not 
likely to hold a PharmD degree, and not likely to have 
residency training. In comparison, pharmacists who are 35 
years old or younger are very different, with most being 
female, holding a PharmD degree, and a significant 
proportion having residency training. It is not surprising that 
younger pharmacists are more likely to comprise the ‘Other 
Activity Pharmacist,’ ‘Patient Care Provider who also Provides 
Medication,’ and ‘Patient Care Provider’ segments and that 
older pharmacists are more likely to comprise the 
‘Medication Provider’ and ‘Medication Provider who also 
Provides Patient Care’ segments in light of trends in 
pharmacist training. Table 4 shows similar findings when Year 
of Licensure cohorts are described. The transformations that 
took place among years of licensure cohorts are particularly 
striking for the gender, holding a PharmD degree, and 
residency training variables. 
 
Discussion 
 
We identified five pharmacist segments using data from a 
survey of a random sample of pharmacists conducted in 
2009. The findings showed that recent transformations in 
pharmacy education regarding the Doctor of Pharmacy 
(Pharm.D) degree as the sole accredited professional degree 
for pharmacy in the United States and the increase in 
pharmacist residency training has created new competencies 
which translate into capacity in the pharmacy profession for 
taking on expanded responsibility for optimizing medication 
use in the U.S. health care system.  
 
The findings showed that, in 2009, 41% of U.S. pharmacists 
were devoted wholly to medication providing (Medication 
Providers). Forty-three percent of pharmacists contributed 
significantly to patient care service provision (Medication 
Providers who also Provide Patient Care, The Patient Care 
Providers who also Provide Medication, and The Patient Care 
Providers) and the remaining 16% (Other Activity 
Pharmacists) contributed most of their time to 
business/organization management, research, education, and 
other health-system improvement activities. However, 
pharmacists who are most visible to the public work in 
community pharmacy practice settings and almost eight out 
of 10 pharmacists who are “Medication Providers” work in 
these publicly visible and accessible settings. Such visibility of 
Medication Providers may give a public impression that is not 
completely accurate regarding the capacity for pharmacist 
provision of patient care and for the complete scope of 
pharmacist contributions to the U.S. health care system. 
 
The findings also showed that older pharmacists, who are 
more likely to exit the workforce before younger pharmacists 
will, are most likely to be in the “Medication Provider” 
segment of pharmacists. Thus, as over 10,000 new 
pharmacists are being licensed each year under the new 
paradigm of training and the older pharmacists exit the 
workforce, the capacity of the pharmacist workforce for 
provision of patient care is likely to be even more 
pronounced. 
 
The findings also suggest that pharmacists who may be in the 
“Medication Provider” or the “Medication Provider who also 
Provides Patient Care” segments, but not likely to exit the 
workforce in the near future, would be open to retraining and 
redeployment. These pharmacists reported that they would 
like to spend less time in medication providing and more time 
in provision of patient care services (see Tables 3 and 4). We 
propose that the majority of these pharmacists would be 
willing to move into more patient care services roles as 
training and opportunities for redeployment present 
themselves. These findings are consistent with the Holland-
Nimmo practice change model [32-36] and guidance for 
making this transition already exists for the pharmacy 
profession [32-36].    
 
Based on our findings, we propose that the pharmacy 
profession currently has, and will continue to build, capacity 
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for contributing to the U.S. health care system in roles for 
which they have been identified which include: (1) 
medication care coordinators for patient-centered medical 
homes [7-8] and primary care teams [9-12], (2) members of 
chronic disease management teams that focus on ‘episodes’ 
of care in which related services are packaged together [11, 
13-14], and (3) being the healthcare professional responsible 
for ensuring optimal medication therapy outcomes through 
medication therapy management (MTM) service provision [3, 
11, 15-22]. However, as shifts in professional roles occur, a 
great deal of capacity is required related to new service 
provision as well as strategic decisions regarding educational 
training,  professional training and redeployment, updates to 
practice acts and regulations, new documentation and billing 
systems, enhanced information exchange, collaborative 
practice models, infrastructure, technology, policy, and new 
business models. Resources are scarce, so an understanding 
of the most appropriate timing for making such changes can 
lead to cost-effective use of limited resources for improving 
patient care [25].  In the next section of this paper, we 
propose several ideas to consider as pharmacist capacity is 
further developed and integrated into the U.S. healthcare 
system.  
 
Ideas for Consideration as Pharmacist Capacity is Developed 
and Integrated into Healthcare  
 
Our findings indentified five clusters (segments) of 
pharmacists and our description of these segments provided 
insight regarding how the pharmacist workforce might evolve 
in terms of capacity for patient care over time. In light of 
these findings, we offer eight ideas for consideration as 
pharmacist capacity is further developed and integrated into 
the U.S. healthcare system. 
 
First, what are future training needs for pharmacists to 
connect their capacity with future health care system needs? 
We suggest that continual improvements to Doctor of 
Pharmacy (Pharm.D.) training will be needed; especially the 
development of team-based, interprofessional training that 
will help health care providers learn about and experience 
team-based patient care. Also, expansion of pharmacy 
residencies (with suitable funding for such training) could 
help meet the advanced training needs for pharmacists. We 
propose that efforts to create “industry norms” that would 
require pharmacy residency training as a condition for certain 
types of pharmacist employment would help position such 
residencies for legitimate consideration of graduate medical 
education (GME) funding. Such norms also could provide 
assurances to other healthcare professionals regarding 
pharmacists’ competence for providing patient care. 
 
Second, community pharmacy practice business models are 
still focused primarily on medication providing. There are new 
models emerging in community pharmacies that utilize 
advanced logistics (e.g. centralized fill), technology (e.g. bar 
code scanning, e-prescribing, robotics), technicians, specialty 
pharmacy services, corporate (in-house) pharmacies, and 
new patient care service models. However, we believe that it 
is important to monitor the rate of discontinuance for some 
community pharmacy business models as well as monitoring 
the adoption of new business models that would help 
pharmacists fulfill their potential in the health care system 
[24-25]. Where and how pharmacists might contribute to 
ensure access to medications and associated services are 
questions that will need to be addressed. In addition, supply 
and demand balance or imbalance for pharmacists should be 
monitored as these changes occur.   
 
Third, pharmacy practice acts and other health profession 
practice acts (that define scope of practice) will need 
updating on an ongoing basis to reflect and accommodate 
new roles for health professionals and for team-based care. 
In pharmacy, the National Association of Boards of Pharmacy 
(www.napb.net) could take the lead for updating the 
Pharmacy Model Practice Act that could be utilized by state 
boards of pharmacy as they develop their states’ practice 
acts. New thinking about what embodies pharmacy practice 
in the health care system is continually needed. Agreement 
on such things as provider status and scope of practice is 
needed, including consensus from other health care fields 
and systems. 
 
Fourth, significant work and progress are needed regarding 
the alignment of payment policies for not only supporting 
new roles and services but also to provide adequate payment 
for the providers of these services and evidence of cost-
effectiveness for payers of these services. According to the 
2008, 2009, and 2010 Medication Therapy Management 
Digests and Environmental Scans [37-40], the most significant 
barriers to offering Medication Therapy Management 
services for pharmacist providers were related to billing, 
staffing adjustments, and payment levels. For the payers of 
these services, the most significant challenges to overcome 
were related to getting patients to engage in the service 
offerings, evidence of tangible outcomes, and having 
sufficient numbers of service providers in their patient 
population service areas. Alignment of payment policies 
would help overcome some of these barriers for both 
providers and payers.  
 
Fifth, we propose that flexibility in medical / health care 
home designs could create innovative and responsive 
practice structures that integrate pharmacist expertise for 
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medication therapy coordination and management under 
varying geographic regions, practice setting types, and 
patient population types [8]. Balancing such flexibility with 
the need for standards of care is a challenge that needs to be 
addressed in the reforming health care system. 
 
Sixth, all members of collaborative health care teams, 
including pharmacists, must have access to necessary patient 
health and treatment records to support and inform their 
patient care service and decision-making functions [8]. Such 
access should include both the authority and responsibility to 
input information into these records to facilitate team-based 
collaborative care. Coming to consensus about what 
information is (1) proprietary, (2) related to business 
functions, and (3) related to patient health and treatment is 
not an easy task. However, we believe it will have immense 
impact on the ability of pharmacists to contribute their full 
capacity to the developing health care system. 
 
Seventh, discussion regarding pharmacists’ contributions to 
patient care that is comprised of bundles of services into 
“episodes of care” will be important. By packaging related 
services together in a way that supports high-quality, lower-
cost care, providers, payers, and patients could begin to view 
episodes of care as a unified patient care experience rather 
than a series of disparate services. For example, products and 
services associated with the treatment of diabetes could be 
bundled in a way to influence overall pay-for-performance 
outcome measures. Pharmacist capacity for medication 
coordination throughout the whole episode of care could be 
valuable for improving quality and avoiding waste in 
medication therapy. As mentioned previously, payment 
redesign in addition to care redesign will need to be 
addressed to bring pharmacists’ full capacity to fruition. 
 
Finally, we suggest that efforts to help bring the U.S. health 
consumer’s perceptions of pharmacists and the roles they 
play in health care more in line with pharmacists’ true 
capacity for patient care would be helpful in making 
transformations in health care. We believe that consensus 
within the pharmacy profession and collaborative health care 
teams overall regarding processes of pharmacist-provided 
patient care and language that is used as care is provided to 
patients would have more impact on changing patients’ 
perceptions than public service campaigns or advertising. For 
example, pharmacists who hold a Pharm.D. degree could be 
referred to as the patient’s Doctor of Pharmacy. This would 
not only identify the practitioner’s training but also identify 
his or her area of expertise. This idea is similar to telling 
patients that they will see their Doctor of Internal Medicine 
or their Doctor of Orthopedics.   
 
Another example of building consensus for the purpose of 
creating clear expectations to patients would be to refer to 
medication therapy and coordination visits in a common way. 
Currently, the term “Medication Therapy Management” is 
being used. Bringing consensus to the term used and placing 
it into common usage would help advance the public’s 
perception of pharmacists’ roles in the health care system. 
We believe that the public should be clear regarding the 
different roles that their prescription order fulfillment 
pharmacist has in comparison to their medication therapy 
management pharmacist. This is similar to the different roles 
that are identified with different physicians (e.g. internal 
medicine physician and surgeon). 
 
Limitations 
 
The results and our interpretation of them should be 
tempered with the limitations of the study. The results are 
based on respondents’ self reports, raising questions 
regarding the extent to which respondents gave socially 
desirable responses.  
 
Pharmacist respondents were geographically diverse in that 
all regions of the United States were represented in 
proportion to the U.S. population and in proportion to our 
sampling frame [27]. However, some individual states were 
over-represented (e.g. Montana) and some states were 
under-represented (e.g. New Mexico) [27]. Thus, while we 
achieved good geographic coverage, some states were 
disproportionately represented in this study. To overcome 
this limitation, we analyzed only aggregate data and not 
state- or region-specific data. 
 
Non-response bias is another limitation. It is possible that 
responders were more interested in the topic we studied or 
had stronger opinions about the questions we asked than 
those who chose not to respond. Our evaluation of non-
response bias showed that late responders were more likely 
to be: working as a pharmacist, younger, and having a 
PharmD degree than early responders. These same 
characteristics are likely to be reflected in the non-
responders to this study and should be considered when 
interpreting the reported findings. 
 
For our analysis, usable data from respondents working in 
pharmacy or a pharmacy related field were used. While our 
findings are representative of pharmacists working in 
pharmacy or a pharmacy related field, it should be noted that 
our analysis did not include licensed pharmacists who were 
outside of these domains (retired, unemployed, or working 
outside of a pharmacy related field). 
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The definitions we used for medication providing and patient 
care services were newly developed for the 2009 survey and 
differed from previous national pharmacist workforce surveys 
conducted in 2000 and 2004 [27-29]. Thus, no comparisons 
were possible to previous years. However, we developed the 
work activity definitions based upon what we learned from 
earlier surveys, namely that pharmacists view medication 
providing and associated patient counseling as a unified 
process and service. We reflected that notion for our 2009 
survey and defined patient care services as being separate 
from the medication providing process. Our findings suggest 
that responders were able to interpret our new definitions in 
the manner in which we developed them and that our 
findings can be considered an accurate reflection of 
pharmacist work. 
 
Our cluster analysis was based upon one national sample of 
pharmacists. In order to test the stability of our cluster 
analysis, we replicated our analysis using data from the 2009 
Minnesota Pharmacy Workforce Survey [41]. Using those 
data, the same five clusters were achieved with extremely 
similar results for the descriptions of each cluster. Findings 
from that analysis are available from the corresponding 
author. 
 
Finally, all of the respondents to this survey were first 
licensed before 2007. Therefore, even though our survey was 
conducted in 2009, our sampling frame had a lag time so that 
pharmacists newly licensed from 2007 through the present 
were not included in the sample. This limitation must be 
considered, especially when interpreting findings related to 
year of licensure, age, or other time dependent variable. 
Thus, it is likely that we underestimated the proportion of 
pharmacists working in patient care areas since younger 
pharmacists typically took on those roles.  
 
Conclusions 
 
Findings from this study revealed five segments of 
pharmacists: (1) Medication Providers, (2) Medication 
Providers who also Provide Patient Care, (3) Other Activity 
Pharmacists, (4) Patient Care Providers who also Provide 
Medication, and (5) Patient Care Providers. The findings 
showed that older pharmacists, who are most likely to exit 
the workforce before younger pharmacists do, are most likely 
to be in the “Medication Provider” segment of pharmacists. 
Thus, as over 10,000 new pharmacists are being licensed each 
year under the new paradigm of training and the older 
pharmacists exit the workforce, the capacity of the 
pharmacist workforce for provision of patient care will be 
even more pronounced. We conclude that recent 
transformations in pharmacy education regarding the Doctor 
of Pharmacy (Pharm.D) degree as the sole accredited 
professional degree for pharmacy in the United States and 
the increase in pharmacist residency training has built 
capacity in the pharmacy profession for taking on expanded 
responsibility for optimizing medication use in the U.S. health 
care system.  
 
The findings also suggest that pharmacists who may be in the 
“Medication Provider” or “The Medication Provider who also 
Provides Patient Care” segments, but not likely to exit the 
workforce in the near future, would be open to retraining and 
redeployment. These pharmacists reported that they would 
like to spend less time in medication providing and more time 
in provision of patient care services. We propose that the 
majority of these pharmacists would be willing to move into 
more patient care services roles as training and opportunities 
for redeployment present themselves.  
 
Based on our findings, we propose that the pharmacy 
profession currently has, and will continue to build, capacity 
for contributing to the U.S. health care system in new roles 
for which they have been identified. However, as shifts in 
professional roles occur, a great deal of capacity is required 
related to new service provision as well as strategic decisions 
regarding educational training,  professional training and 
redeployment, updates to practice acts and regulations, new 
documentation and billing systems, enhanced information 
exchange, collaborative practice models, infrastructure, 
technology, policy, and new business models. Resources are 
scarce, so an understanding of the most appropriate timing 
for making such changes can lead to cost-effective use of 
limited resources for improving patient care.   
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Figure 1: Proportion of U.S. Pharmacists by Segment in Descending Size 
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Table 1 
Description of Pharmacist Segments 
 
 
Pharmacist Segment Segment Size  
(% of total) 
Mean Percentage Time     
(+/- s. d.) Devoted to 
Medication Providing 
Mean Percentage Time     
(+/- s. d.) Devoted to   
Patient Care 
    
1: Medication Provider n= 496 (41%) 
 
88% +/- 9 5% +/- 4 
2: Medication Provider who also 
Provides  Patient Care  
n = 303 (25%) 65% +/- 11 19% +/- 7 
3: Other Activity Pharmacist n = 193 (16%) 
 
5% +/- 8 3% +/- 6 
4: Patient Care Provider who also 
Provides Medication 
n = 142 (12%) 33% +/- 17 43% +/- 11 
5: Patient Care Provider n = 66 (6%) 
 
5% +/- 8 82% +/- 13 
 
Total 
 
N = 1,200 
 
58% +/- 34 
 
17% +/- 21 
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Table 2 
Comparison of U.S. Pharmacist Segments 
 
 Medication 
Provider 
(n = 496) 
Medication 
Provider who 
also provides 
Patient Care 
(n = 303) 
Other 
Activity 
Pharmacist 
(n = 193) 
Patient Care 
Provider who 
also Provides 
Medication 
(n = 142) 
Patient 
Care 
Provider 
(n = 66) 
Overall 
(n=1,200) 
       
Demographic 
Characteristics 
      
Mean Age (years) 
ANOVA p< 0.001 
52.0 50.2 49.2 45.6 47.4 50.1 
 
Female Gender (%) 
X
2
 p < 0.001 
41% 48% 40% 64% 59% 47% 
Hold PharmD Degree (%) 
X
2
 p < 0.001 
17% 17% 42% 40% 53% 26% 
Mean Year of First 
Licensure 
ANOVA p< 0.001 
1982 1983 1984 1988 1988 1983 
Residency Training (%) 
X
2
 p < 0.001 
3% 4% 19% 25% 26% 9% 
White/Caucasian Ethnicity 
(%) 
X
2
 p = 0.047 
88% 85% 87% 77% 86% 86% 
       
Work Contributions       
Mean Hrs Worked /Wk 
ANOVA p< 0.001 
35.6 38.0 44.7 37.2 39.8 38.1 
Work Part Time (30 hrs per 
week or less) (%) 
X
2
 p < 0.001 
29% 20% 13% 30% 18% 24% 
Work in Urban Area with 
Population Over 50,000 (%) 
X
2
 p = 0.002 
79% 79% 93% 88% 92% 83% 
Practicing as a Pharmacist 
(%) 
X
2
 p < 0.001 
89% 93% 45% 94% 97% 84% 
       
Current Work Setting 
(Column %) 
X
2
 p < 0.001 
      
Community Pharmacy
a
 78% 67% 10% 23% 1% - 
Hospital  Setting 15% 25% 30% 54% 64% - 
Other, Licensed Pharmacy 
Setting
b
 
7% 7% 15% 16% 27% - 
Other, Setting Not Licensed 
as a Pharmacy
c 
<1% 1% 45% 7% 8% - 
       
Current Work Setting 
(Row %) 
X
2
 p < 0.001 
      
Community Pharmacy
a
 (n = 
645) 
60% 32% 3% 5% <1% - 
Hospital  Setting  
(n = 325) 
23% 24% 17% 23% 13% - 
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Other, Licensed Pharmacy 
Setting
b
 
(n = 126) 
29% 16% 23% 18% 14% - 
Other, Setting Not Licensed 
as a Pharmacy
c
 (n = 104) 
1% 2% 83% 10% 5% 
- 
       
Mean % of Time Currently 
Spent in Work Activities 
      
Medication Providing 
ANOVA p< 0.001 
88% 65% 5% 33% 5% 58% 
Patient Care Services 
ANOVA p<0.001 
5% 19% 3% 43% 82% 17% 
Business / Organization 
Management 
ANOVA p<0.001 
5% 10% 41% 9% 3% 12% 
Research 
ANOVA p<0.001 
<1% 1% 18% 4% 3% 4% 
Education 
ANOVA p< 0.001 
2% 4% 8% 8% 6% 4% 
Other
d
 
ANOVA p< 0.001 
1% 1% 25% 5% 2% 5% 
       
Mean % of Time Desired to 
Spend in Work Activities 
      
Medication Providing 
ANOVA p< 0.001 
71% 52% 7% 26% 6% 47% 
Patient Care Services 
ANOVA p<0.001 
16% 31% 9% 44% 81% 26% 
Business / Organization 
Management 
ANOVA p<0.001 
5% 8% 35% 9% 2% 11% 
Research 
ANOVA p<0.001 
21% 3% 20% 7% 4% 6% 
Education 
ANOVA p< 0.001 
5% 5% 10% 10% 7% 7% 
Other
d
 
ANOVA p< 0.001 
<1% 1% 17% 4% <1% 4% 
       
 
a
 “Community Pharmacy Practice” included: independent, chain, mass merchandiser and supermarket pharmacies. 
 
b
 “Other, Licensed Pharmacy Setting” included: nursing home, long term care, health maintenance organization, nuclear, clinic-based, mail service, 
central fill, and home health/infusion pharmacies. 
 
c
 “Other, Setting Not Licensed as a Pharmacy” included: pharmacy benefit administration, academic, government administration, pharmaceutical 
industry, consulting companies, professional associations, and other organizations that were not licensed as a pharmacy. 
 
d
 Other includes activities such as: computer analysis, audit control, continuing education, grants, committee work, communications, consultation, 
data analysis, drug information services, formulary management, systems implementation, inspections, investigations, information technology 
work, manufacturing, marketing, medication safety, meetings, policy work, problem resolution, quality assurance, regulatory issues, and writing. 
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Table 3 
Comparison of U.S. Pharmacist Age Cohorts 
 
N does not total 1,200 due to missing data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age Cohort  
(years of age) 
Female 
Gender 
Hold 
PharmD 
Degree 
Year of 
First 
Licensure 
Residency 
Training 
% in  
Cluster 1 
Medication 
Provider 
% in  
Cluster 2 
Medication 
Provider who 
also provides 
Patient Care 
 
% in  
Cluster 3 
Other Activity 
Pharmacist 
% in  
Cluster 4 
Patient Care 
Provider who 
also Provides 
Medication 
% in  
Cluster 5 
Patient 
Care 
Provider 
      
< or equal to 30 (n = 
32) 
78% 84% 2004 31% 41% 6% 22% 13% 19% 
31 to 35 (n = 116) 64% 67% 2000 22% 33% 23% 16% 23% 5% 
36 to 40 (n = 141)  70% 40% 1995 11% 37% 31% 15% 13% 5% 
41 to 45 (n = 140) 69% 32% 1991 11% 38% 24% 16% 18% 5% 
46 to 50 (n = 159) 54% 18% 1986 9% 36% 28% 18% 11% 7% 
51 to 55 (n = 213) 49% 13% 1981 7% 44% 25% 17% 10% 5% 
56 to 60 (n = 168) 26% 15% 1976 4% 41% 25% 18% 9% 7% 
61 to 65 (n = 106) 16% 9% 1971 9% 42% 24% 21% 9% 6% 
66 to 70 (n = 65) 9% 6% 1965 2% 63% 26% 6% 3% 2% 
Greater than 70 (n = 
48) 
6% 9% 1958 0% 71% 21% 6% 2% 0% 
 
OVERALL (N = 1,188) 
 
47% 
 
26% 
 
1983 
 
9% 
 
42% 
 
25% 
 
16% 
 
12% 
 
6% 
 
 
 
X
2
 
p < 
0.001 
 
X
2
 
p < 
0.001 
 
ANOVA 
p < 0.001 
 
X
2
 
p < 0.001 
 
Chi-Square 
p < 0.001 
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Table 4 
Comparison of U.S. Pharmacist Year of Licensure Cohorts 
 
N does not total 1,200 due to missing data. 
 
 
 
 
 
 
Year of Licensure Cohort 
(year of first licensure) 
Female 
Gender 
Age  
(years) 
Hold 
PharmD 
Degree 
Residency 
Training 
% in 
Cluster 1 
 
Medication 
Provider 
% in  
Cluster 2 
 
Medication 
Provider 
who also 
provides 
Patient 
Care 
 
% in  
Cluster 3 
 
Other 
Activity 
Pharmacist 
% in  
Cluster 4 
 
Patient Care 
Provider 
who also 
Provides 
Medication) 
% in  
Cluster 5 
 
Patient 
Care 
Provider 
      
2005 to 2006 (n = 23) 70% 30.9 96% 30% 52% 4% 9% 13% 22% 
2000 to 2004 (n = 101) 66% 33.7 75% 22% 33% 23% 18% 20% 7% 
1995 to 1999 (n = 136) 67% 38.2 46% 13% 31% 27% 18% 19% 5% 
1990 to 1994 (n = 142) 66% 42.0 30% 14% 44% 23% 12% 11% 10% 
1985 to 1989 (n = 141) 58% 47.0 17% 6% 38% 26% 17% 15% 4% 
1980 to 1984 (n =164) 50% 51.2 20% 7% 35% 29% 21% 9% 6% 
1975 to 1979 (n = 188) 39% 55.6 12% 6% 47% 23% 16% 9% 5% 
1970 to 1974 (n = 133) 22% 60.7 7% 3% 39% 30% 17% 8% 6% 
1965 to 1969 (n = 74) 10% 65.4 5% 7% 47% 24% 18% 10% 1% 
1960 to 1964 (n = 41) 10% 70.0 8% 3% 71% 20% 7% 2% 0% 
Before 1960 (n = 33) 6% 77.1 9% 0% 73% 21% 6% 0% 0% 
 
OVERALL (N = 1,176) 
 
47% 
 
51.6 
 
26% 
 
9% 
 
41% 
 
25% 
 
16% 
 
12% 
 
6% 
 
 
 
X
2
 
p < 0.001 
 
ANOVA 
p < 0.001 
 
X
2
 
p < 0.001 
 
X
2
 
p < 0.001 
 
Chi-Square, p < 0.001 
